Maiden (NASDAQ:MHLD) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Maiden (NASDAQ:MHLDGet Rating) in a research note released on Tuesday. The brokerage issued a sell rating on the insurance provider’s stock.

Maiden Price Performance

Shares of NASDAQ MHLD opened at $2.13 on Tuesday. The firm has a market cap of $185.67 million, a PE ratio of 5.20 and a beta of 1.15. The firm has a fifty day moving average of $2.16 and a 200 day moving average of $2.17. The company has a debt-to-equity ratio of 1.23, a quick ratio of 0.46 and a current ratio of 0.46. Maiden has a one year low of $1.84 and a one year high of $3.24.

Institutional Investors Weigh In On Maiden

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. boosted its stake in Maiden by 754.1% during the 2nd quarter. Goldman Sachs Group Inc. now owns 424,127 shares of the insurance provider’s stock worth $823,000 after purchasing an additional 374,472 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Maiden by 4.7% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 189,053 shares of the insurance provider’s stock worth $456,000 after purchasing an additional 8,537 shares during the last quarter. Jane Street Group LLC acquired a new stake in Maiden during the 2nd quarter worth $113,000. Zebra Capital Management LLC boosted its stake in Maiden by 80.3% during the 1st quarter. Zebra Capital Management LLC now owns 40,354 shares of the insurance provider’s stock worth $97,000 after purchasing an additional 17,978 shares during the last quarter. Finally, Cubist Systematic Strategies LLC acquired a new stake in Maiden during the 2nd quarter worth $53,000. Institutional investors and hedge funds own 29.87% of the company’s stock.

About Maiden

(Get Rating)

Maiden Holdings, Ltd., through its subsidiaries, provides property and casualty reinsurance solutions to regional and specialty insurers in Europe, the United States, and internationally. It operates in two segments: Diversified Reinsurance and AmTrust Reinsurance. The company writes treaties on a quota share basis and excess of loss basis.

Read More

Receive News & Ratings for Maiden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maiden and related companies with MarketBeat.com's FREE daily email newsletter.